Sleep Cycle 過去の業績
過去 基準チェック /26
Sleep Cycleは、平均年間22.4%の収益成長を遂げていますが、 Software業界の収益は、年間 成長しています。収益は、平均年間22.2% 7.1%収益成長率で 成長しています。 Sleep Cycleの自己資本利益率は40.4%であり、純利益率は11%です。
主要情報
22.42%
収益成長率
21.46%
EPS成長率
| Software 業界の成長 | 15.75% |
| 収益成長率 | 7.10% |
| 株主資本利益率 | 40.37% |
| ネット・マージン | 11.03% |
| 次回の業績アップデート | 23 Oct 2026 |
最近の業績更新
Recent updates
ナラティブ更新 • Jul 02
SLEEP: Takeover Offer And Data Partnerships Will Shape Balanced Future Prospects
Analysts have revised their price target on Sleep Cycle to SEK26.0 from SEK34.5. This reflects updated views on the company’s fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News for Sleep Cycle Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK500 million, offering a cash consideration of SEK24.5 per share.
ナラティブ更新 • Jun 18
SLEEP: Apnea Launch And AI Sleep Scoring Will Support Margin Recovery
Analysts have kept their SEK 35.0 price target for Sleep Cycle unchanged, citing updated assumptions that include slightly higher discount rates, revised revenue growth expectations, a materially higher profit margin outlook, and a lower future P/E multiple as key reasons for maintaining this fair value view. What’s in the News for Sleep Cycle Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK 500 million in cash, at SEK 24.5 per share.
ナラティブ更新 • Jun 04
SLEEP: Medical Sleep Apnea Breakthrough And AI Coaching Will Drive Long Term Upside
Analysts have raised their price target on Sleep Cycle from SEK 28.83 to SEK 30.50, citing updated assumptions around revenue growth, profit margins and future P/E levels as key drivers behind the new valuation view. What's in the News Altor Fund V (No. 2) AB, managed by Altor Equity Partners AB, has proposed to acquire Sleep Cycle AB (publ) for approximately SEK 500 million in cash, offering SEK 24.50 per share.ナラティブ更新 • May 07
SLEEP: Respiratory Research And Sleep Apnea Solution Will Drive Long Term Upside
Analysts have trimmed their price target on Sleep Cycle from SEK30.75 to about SEK28.83, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E multiples. What's in the News Sleep Cycle renewed its partnership with Revolut through June 2027, keeping the app included in exclusive offerings for Premium, Metal and Ultra customers and giving access to a large, premium user base for its sleep optimization features (Client Announcements).分析記事 • May 02
Earnings Release: Here's Why Analysts Cut Their Sleep Cycle AB (publ) (STO:SLEEP) Price Target To kr29.00
It's been a sad week for Sleep Cycle AB (publ) ( STO:SLEEP ), who've watched their investment drop 17% to kr15.34 in...ナラティブ更新 • Apr 21
SLEEP: Respiratory Research And Apnea Launch Will Support 2027 Margin Recovery
Analysts keep their SEK35.0 price target for Sleep Cycle unchanged, citing offsetting shifts in key model inputs such as slightly lower revenue growth assumptions, a reduced profit margin outlook, a marginally lower discount rate and a higher future P/E multiple. What's in the News Sleep Cycle renewed its partnership with Revolut through June 2027, keeping its premium features bundled into Revolut’s Premium, Metal and Ultra tiers and extending reach to Revolut’s global user base (Client Announcements).ナラティブ更新 • Apr 04
SLEEP: Respiratory Disease Research Collaboration Will Drive Long Term Upside Potential
Analysts now see Sleep Cycle's fair value at SEK 30.75, down from SEK 39.50, reflecting updated views on revenue growth, profit margins and an outlook that applies a higher discount rate along with a much higher future P/E assumption. What's in the News Sleep Cycle introduced an AI-powered Sleep Score that focuses on duration, quality and routine.ナラティブ更新 • Mar 21
SLEEP: Respiratory Research Collaborations Will Support 2027 Margin Recovery Upside
Analysts have maintained their SEK 35.00 price target on Sleep Cycle, with only small tweaks to assumptions around discount rate, revenue, profit margin and future P/E, reflecting a broadly steady outlook on the shares. What's in the News Sleep Cycle began a five-year research collaboration with The Delphi Group at Carnegie Mellon University, providing deidentified sleep-based cough and breathing data to support research on respiratory disease surveillance and early detection of seasonal and emerging outbreaks, including influenza, RSV and SARS-CoV-2.ナラティブ更新 • Mar 06
SLEEP: Research Partnerships And 2027 Margin Recovery Will Drive Long Term Upside
Analysts are keeping their SEK price target for Sleep Cycle unchanged. A fair value of SEK 35.00 is maintained, as small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions effectively offset one another.ナラティブ更新 • Feb 19
SLEEP: Licensing Deals And 2027 Margin Recovery Will Drive Long Term Upside
Analysts have reduced their Sleep Cycle fair value estimate from SEK 43.0 to SEK 35.0, reflecting a higher discount rate, a lower assumed future P/E, and slightly softer margin expectations, partly offset by a higher projected revenue growth rate. What's in the News Sleep Cycle issued earnings guidance indicating an EBIT margin of about 5% for 2026, linked to increased forward-looking investments.分析記事 • Feb 09
These Analysts Just Made An Downgrade To Their Sleep Cycle AB (publ) (STO:SLEEP) EPS Forecasts
One thing we could say about the analysts on Sleep Cycle AB (publ) ( STO:SLEEP ) - they aren't optimistic, having just...分析記事 • Feb 07
Sleep Cycle (STO:SLEEP) Has Announced That Its Dividend Will Be Reduced To SEK0.53
Sleep Cycle AB (publ) ( STO:SLEEP ) is reducing its dividend from last year's comparable payment to SEK0.53 on the 20th...ナラティブ更新 • Feb 04
SLEEP: Data Partnerships Will Drive Future Upside For This Undervalued Play
Analysts have lifted their price target for Sleep Cycle from $26.00 to $34.50, citing updated assumptions that combine a lower discount rate and higher projected profit margin with a different revenue growth outlook and a higher future P/E multiple. What's in the News Sleep Cycle and the UK Health Security Agency began a 12 week research collaboration to test whether anonymised, privacy preserved data from the Sleep Cycle app and its Cough Radar tool can support respiratory disease surveillance and early detection of patterns for viruses such as influenza, RSV and Covid 19 (Key Developments).ナラティブ更新 • Jan 21
SLEEP: Expanding Licensing And AI Coaching Will Drive Long Term Upside
Analysts have maintained their fair value estimate for Sleep Cycle at $43.00. They cite more cautious assumptions on revenue growth and profit margins, together with a higher future P/E outlook, as key factors behind the unchanged target.ナラティブ更新 • Jan 06
SLEEP: Expanding Licensing And AI Sleep Coaching Will Support Long Term Upside
Analysts have kept their fair value estimate for Sleep Cycle steady at US$43.00, pointing to only small tweaks in the discount rate, expected revenue growth and profit margin, along with a slightly lower future P/E assumption as the basis for the unchanged target. What's in the News Sleep Cycle signed a multi year SDK licensing agreement with a global IoT and smart home device brand, allowing the customer to integrate the company’s audio based sleep tracking analysis into its devices and broadening Sleep Cycle’s technology licensing activity (Key Developments).分析記事 • Jan 04
There's No Escaping Sleep Cycle AB (publ)'s (STO:SLEEP) Muted Earnings
Sleep Cycle AB (publ)'s ( STO:SLEEP ) price-to-earnings (or "P/E") ratio of 9.2x might make it look like a strong buy...ナラティブ更新 • Dec 15
SLEEP: Long Term Profit Margins Will Drive Stronger Future Upside Potential
Analysts have trimmed their price target on Sleep Cycle from approximately $49.00 to $43.00. This reflects expectations for slower revenue growth, partially offset by higher long term profit margins and a lower future price to earnings multiple.分析記事 • Sep 09
Sleep Cycle AB (publ) (STO:SLEEP) Held Back By Insufficient Growth Even After Shares Climb 30%
Sleep Cycle AB (publ) ( STO:SLEEP ) shares have had a really impressive month, gaining 30% after a shaky period...分析記事 • Aug 27
Weekly Picks: 💸 A dividend-rich sleep-tech play few investors are watching, and 2 other picks.
The main catalyst behind Sleep Cycle’s upside potential, why JB Hi-Fi might have lost its point of difference, and the bear, base and bull case for Figma.
ナラティブ更新 • Aug 23
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Q2 2025 Update (updated 250823) Subscriptions continue to decline (-3%), leading to a top-line contraction that is likely to persist. However, partnerships are gaining momentum , with the company highlighting on the conference call that these could carry a more favorable margin profile.ナラティブ更新 • Aug 22
Expanding Technology And Sleep Apnea Initiatives Will Open New Opportunities
Sleep Cycle’s consensus price target has been revised upward, driven primarily by an increase in its future P/E multiple and a modest improvement in net profit margin, resulting in a new fair value estimate of SEK44.75. What's in the News Launched in-app promotion platform in collaboration with HelloFresh, Factor, and YouFoodz, enabling external brands to target Sleep Cycle’s user base with curated wellness offers and supporting expansion of partnership programs.分析記事 • Apr 30
Earnings Update: Sleep Cycle AB (publ) (STO:SLEEP) Just Reported And Analysts Are Trimming Their Forecasts
As you might know, Sleep Cycle AB (publ) ( STO:SLEEP ) last week released its latest first-quarter, and things did not...分析記事 • Apr 29
The Market Doesn't Like What It Sees From Sleep Cycle AB (publ)'s (STO:SLEEP) Earnings Yet As Shares Tumble 34%
Sleep Cycle AB (publ) ( STO:SLEEP ) shares have had a horrible month, losing 34% after a relatively good period...分析記事 • Apr 08
Sleep Cycle's (STO:SLEEP) Dividend Will Be Increased To SEK3.00
Sleep Cycle AB (publ) ( STO:SLEEP ) has announced that it will be increasing its dividend from last year's comparable...
新しいナラティブ • Mar 18
Medical-Grade Sleep Apnea Certification Will Open New Healthcare Partnerships
Exploring medical-grade certification and new revenue streams could enhance profitability, opening healthcare markets through partnerships and innovation.分析記事 • Mar 06
Sleep Cycle's (STO:SLEEP) Upcoming Dividend Will Be Larger Than Last Year's
Sleep Cycle AB (publ) ( STO:SLEEP ) has announced that it will be increasing its dividend from last year's comparable...分析記事 • Feb 10
Sleep Cycle (STO:SLEEP) Is Paying Out A Larger Dividend Than Last Year
Sleep Cycle AB (publ) ( STO:SLEEP ) will increase its dividend from last year's comparable payment on the 15th of April...新しいナラティブ • Feb 10
Sleep Cycle's Revenue Set to Rise 10% with Strong Business Model
Company will continue its trajectory of 10% top line growth p.a. with possibility of more aggressive growth should new business materialize (e.g. data monetization or making the app medical device for収支内訳
収支内訳
Sleep Cycle の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 26 | 222 | 24 | 76 | 0 |
| 31 Mar 26 | 236 | 45 | 69 | 0 |
| 31 Dec 25 | 248 | 53 | 69 | 0 |
| 30 Sep 25 | 257 | 59 | 66 | 0 |
| 30 Jun 25 | 261 | 62 | 64 | 0 |
| 31 Mar 25 | 263 | 65 | 61 | 0 |
| 31 Dec 24 | 262 | 63 | 58 | 0 |
| 30 Sep 24 | 256 | 56 | 56 | 0 |
| 30 Jun 24 | 251 | 55 | 52 | 0 |
| 31 Mar 24 | 243 | 49 | 51 | 0 |
| 31 Dec 23 | 236 | 46 | 53 | 0 |
| 30 Sep 23 | 229 | 39 | 59 | 0 |
| 30 Jun 23 | 224 | 33 | 64 | 0 |
| 31 Mar 23 | 218 | 33 | 65 | 0 |
| 31 Dec 22 | 212 | 34 | 61 | 0 |
| 30 Sep 22 | 206 | 37 | 58 | 0 |
| 30 Jun 22 | 199 | 34 | 59 | 0 |
| 31 Mar 22 | 191 | 14 | 65 | 0 |
| 31 Dec 21 | 183 | 8 | 66 | 0 |
| 30 Sep 21 | 177 | 6 | 69 | 0 |
| 30 Jun 21 | 168 | 12 | 54 | 0 |
| 31 Mar 21 | 163 | 33 | 42 | 0 |
| 31 Dec 20 | 159 | 44 | 35 | 0 |
| 31 Dec 19 | 123 | 42 | 27 | 0 |
| 31 Dec 18 | 93 | 27 | 18 | 0 |
質の高い収益: SLEEPにはSEK10.5M } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が30th June, 2026に影響を及ぼしています。
利益率の向上: SLEEPの現在の純利益率 (11%)は、昨年(23.9%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: SLEEPの収益は過去 5 年間で年間22.4%増加しました。
成長の加速: SLEEPは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: SLEEPは過去 1 年間で収益成長率がマイナス ( -60.8% ) となったため、 Software業界平均 ( 10.1% ) と比較することが困難です。
株主資本利益率
高いROE: SLEEPの 自己資本利益率 ( 40.4% ) は 傑出している と考えられます。
総資産利益率
使用総資本利益率
過去の好業績企業の発掘
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/09/13 04:23 |
| 終値 | 2026/09/11 00:00 |
| 収益 | 2026/06/30 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。
シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Sleep Cycle AB (publ) 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4
| アナリスト | 機関 |
|---|---|
| Oscar Erixon | Carnegie Investment Bank AB |
| Erik Granström | DNB Carnegie |
| Rikard Engberg | DNB Carnegie Commissioned Research |